More on TRAK
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Net revenue | 269.46M |
| Cost of revenue | 149.23M |
| Product development | |
| Selling, general and administrative | 88.61M |
| Total operating expenses | |
| Income (loss) from operations | -3.44M |
| Interest income | 10K |
| Interest expense | |
| Other income | |
| Realized gain on securities | |
| Income (loss) before (provision for) benefit from income taxes | |
| (Provision for) benefit from income taxes, net | 1.05M |
| Net income (loss) | -9.3M |
| Basic net income (loss) per share | |
| Diluted net income (loss) per share | |
| Weighted average common stock outstanding (basic) | 54.94M |
| Weighted average common stock outstanding (diluted) | 54.94M |
Entities mentioned with TRAK
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Trading Radar | View Related Stories »
- Show More...
